Granulocyte monocyte-colony stimulating factor as an agent for wound healing. A study evaluating the use of local injections of a genetically engineered growth factor in the management of wounds with a poor healing prognosis

J Wound Care. 1995 Oct;4(9):400-2.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leg Ulcer / etiology
  • Leg Ulcer / physiopathology
  • Leg Ulcer / therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use*
  • Treatment Outcome
  • Wound Healing / drug effects*

Substances

  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor